Gau-Bischofsheim, Germany

Jürgen Markl



Average Co-Inventor Count = 4.0

ph-index = 1


Location History:

  • 55296 Gau-Bischofsheim, DE (2006)
  • Gau-Bischofsheim, DE (2006 - 2007)

Company Filing History:


Years Active: 2006-2007

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jürgen Markl: Innovator in Nucleic Acid Technology

Introduction

Jürgen Markl is a notable inventor based in Gau-Bischofsheim, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid molecules and their applications in immunology. With a total of four patents to his name, Markl's work has the potential to impact medical research and therapeutic strategies.

Latest Patents

Markl's latest patents focus on nucleic acid molecules that code for haemocyanins, which are important for immunological applications. One of his inventions involves a nucleic acid molecule or construct that codes for a KLH1 haemocyanin, including at least one intron sequence and haemocyanin fusion proteins. This construct can also include a nucleic acid sequence that codes for an antigen. Additionally, he has developed a pharmaceutical composition that comprises the expression product of this nucleic acid and antibodies that can be obtained through immunization of an animal. His work also extends to a similar construct for an HLH2 haemocyanin polypeptide, further emphasizing the versatility and importance of his inventions in tumor identification and immunological screening.

Career Highlights

Throughout his career, Jürgen Markl has worked with various companies, including Biosyn Arzneimittel GmbH. His innovative approach and dedication to research have led to the successful development of multiple patents that contribute to advancements in biotechnology.

Collaborations

Markl has collaborated with notable colleagues such as Benjamin Altenhein and Thomas Stiefel. These partnerships have likely enhanced the scope and impact of his research endeavors.

Conclusion

Jürgen Markl's contributions to the field of biotechnology through his patents on nucleic acid molecules demonstrate his commitment to advancing medical science. His work not only showcases his innovative spirit but also holds promise for future applications in immunology and tumor identification.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…